Study of exosome therapy in healthy volunteers
This trial is testing a new medicine made from tiny particles called exosomes that target a protein called HLA-G. The study is being done in healthy people to check if the medicine is safe and how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You should be generally healthy, with no major medical problems.
- You must be able to understand and agree to the study rules.
- Your organs (like liver and kidneys) must be working normally.
- You cannot be allergic to medicines that target HLA-G.
- You cannot have HIV, hepatitis B, or hepatitis C.
- You cannot have had cancer or anti-cancer treatments.
- You cannot have had a cell therapy or organ transplant before.
- You cannot have a drug or alcohol abuse problem.
- If you are able to have children, you must use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SNH-119014 for the first time in humans. It involves healthy volunteers to check the drug's safety and how the body processes it. It may be a step toward a new treatment for certain conditions.
This study tests a new medicine, ART105, in healthy adults to see if it is safe and how the body handles it. It is an early-stage trial, so it may not directly help you, but you would be contributing to medical research.
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This trial tests a new drug called SOA101 for people with certain advanced cancers that have stopped responding to standard treatments. It aims to see if the drug is safe and if it can help shrink tumors.
This trial tests a new medicine called LY4088044 in healthy people to see how it affects the body. It helps doctors learn about the drug's safety before testing it in patients with a disease.
Hear when a new Targeted Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.